Ladophar schedules EGM to address business adjustments and losses

Lam Dong Pharmaceutical JSC (Ladophar) has announced an Extraordinary General Meeting (EGM) for 2025, following a resolution by its board of directors on October 7, 2025. The meeting, scheduled for November 28, 2025, will take place at the company's headquarters at 18 Ngo Quyen, Cam Ly Ward, Da Lat City, Lam Dong Province. The record date for shareholder attendance is October 27, 2025, with each share granting one voting right.

The EGM's agenda includes key proposals such as supplementing business lines, addressing accumulated losses, and other matters within the general meeting of shareholders' authority. The board of directors has authorized the chairman to finalize meeting logistics, including sending invitations to shareholders and publishing announcements on the company's website.

This resolution is effective from its signing date, with all members of the board of directors, the general director, and relevant departments responsible for its implementation.